BetterLife Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BetterLife Pharma generated cash of -$2,472,410, which is less than the previous year. Cash used in financing activities reached the amount of $2,501,543 last year. Net change in cash is therefore $29,077.
Cash Flow
| 2015 | -52.66K | 0 | 52.68K |
|---|---|---|---|
| 2016 | -229.15K | -1.05K | 335.78K |
| 2017 | -495.06K | 2 | 521.62K |
| 2018 | -488.06K | 1 | 444.75K |
| 2019 | -4.97M | -850.51K | 5.82M |
| 2020 | -7.88M | -1.14M | 12.22M |
| 2021 | -7.16M | -71.55K | 4.08M |
| 2022 | -11.20M | -18.77K | 11.23M |
| 2023 | -1.50M | 165.04K | 1.33M |
| 2024 | -2.47M | 0 | 2.50M |
BETRF Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2019 | 2019 | 2017 | 2017 | 2015 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.30K | 173.51K | 154.72K | 3.28M | 74.8K | 79.30K | 138.69K | 93.87K | 1.17K | 1.04K |
Operating activities | ||||||||||
Net income | -2.89M | -9.37M | -12.15M | -36.35M | -19.58M | -9.14M | -149.50K | -8.22M | -11.99M | -1.00M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 18.43K | 18.43K | 342.81K | 1.40M | 900.65K | 30.93K | 0 | 450 | 455 |
Stock-based compensation expense | 500.26K | 951.06K | 1.23M | 826.63K | 1.59M | 31.56K | 191.26K | 6.60M | 13.69M | 3.47K |
| Deferred income tax benefit | 500.26K | 951.06K | 1.23M | 826.63K | 1.59M | 31.56K | 191.26K | 6.60M | 13.69M | 3.47K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -22.35K | 310 | 181 | -349.89K | -92 | -39 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 349.89K | -589.11K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -701.56K | 2.21M | -1.15M | -993.93K | 1.05M | 470.78K | 659.28K | 0 | 0 | 0 |
Cash generated by operating activities | -2.47M | -1.50M | -11.20M | -7.16M | -7.88M | -4.97M | -488.06K | -495.06K | -229.15K | -52.66K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -96.61K | -542.74K | -853.28K | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 25.06K | -432.92K | 2.77K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 165.04K | -18.77K | -71.55K | -1.14M | -850.51K | 1 | 2 | -1.05K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 2.20M | 833.31K | 11.44M | 1.28M | 16.31M | 1.53M | 410.19K | 0 | 335.78K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 300K | 0 | -250K | -499.92K | -583.58K | -550.15K | 47.15K | 0 | 0 | 0 |
Cash used in financing activities | 2.50M | 1.33M | 11.23M | 4.08M | 12.22M | 5.82M | 444.75K | 521.62K | 335.78K | 52.68K |
Net Change In Cash | 29.07K | -165.20K | 18.79K | -3.12M | 3.20M | -4.50K | -59.10K | 53.44K | 98.96K | 23 |
Cash at end of period | 37.38K | 8.30K | 173.51K | 154.72K | 3.28M | 74.8K | 79.58K | 147.32K | 100.13K | 1.06K |
| Data source | Data source |